BHTRKEVKTKCXOH-UYRINQEQSA-N

BHTRKEVKTKCXOH-UYRINQEQSA-N Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways.

BHTRKEVKTKCXOH-UYRINQEQSA-N Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

BHTRKEVKTKCXOH-UYRINQEQSA-N Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44844	58
QUALITY CONTROL SOLUTIONS LTD.	0755-66853366; 13670046396	ORDERS@QCSRM.COM	China	18899	58
Cato Research Chemicals Inc.	020-81960175-877 18933936954	tianwen.zhan@cato-chem.com	China	7733	58
LGC Science (Shanghai) Ltd.	17717235263	cindy.yang@lgcgroup.com	China	11677	58
Shanghai Beiwanta Biotechnology Co., Ltd.	021-67187366 19901745723	info@bwtlab.com	China	9262	58
guoyungurui	18162595016; 18162595016	3287908757@qq.com	China	10336	58
Nanjing Shizhou Biology Technology Co.,Ltd	17301488900	judy.xia@synzest.com	China	12582	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	19696	58
SHANGHAI ZZBIO CO., LTD.	15102117276 19921389125	tech@zzbioco.com	China	12064	58
TLC Pharmaceutical Standards Ltd.	18012923235	chinasales04@tlcstandards.com.cn	China	4793	58

---

• BHTRKEVKTKCXOH-UYRINQEQSA-N
• [2H5]-Tauroursodeoxycholic Acid
• Tauroursodeoxycholic Acid-d5 (Tauroursodiol-d5)
• Dronedarone Impurity 39
• Tauroursodeoxycholic-d5 Acid (Tauroursodiol-d5)
• 1207294-25-4